• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
API
Click for more information
0.74% $1.35

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Australian Pharmaceutical Industries Limited is a pharmaceutical distributor, and health... Australian Pharmaceutical Industries Limited is a pharmaceutical distributor, and health and beauty retailer. The Company operates through two segments: Australia, which is engaged in the distribution of pharmaceutical, medical, health, beauty and lifestyle products to pharmacies, the purchase and sale of various health, beauty and lifestyle products within the retail industry, and the provision of retail services to pharmacies, and New Zealand, which manufactures and owns rights of pharmaceutical medicines and consumer toiletries. Its services include wholesale product delivery, retail services, marketing programs and business advisory services. Its brands include Priceline & Priceline Pharmacy, which is a health, beauty and wellbeing retailer; Soul Pattinson Chemist, which is a pharmacy brand; Pharmacist Advice, which offers professional service and advice; Club Premium, which is a club for independent pharmacies, and Pharmacy Best Buys, which offers a catalog program.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
API S&P DJI Announces September 2019 Quarterly RebalancePRICE SENSITIVE06/09/19
API Change in substantial holding from CBA22/03/19
API Market update on API-Sigma merger proposalPRICE SENSITIVE13/03/19
API SIG: Update on API proposalPRICE SENSITIVE13/03/19
API API presentation to ASX CEO Connect 19 February 201919/02/19
API Change of Director's Interest Notice14/02/19
API Appendix 3B14/02/19
API Change of Director's Interest Notice31/01/19
API MDC: Medlab Expands Nutraceutical Range to 2,100 PharmaciesPRICE SENSITIVE30/01/19
API API - Change in Company Office Holders29/01/19
API Change of Director's Interest Notice29/01/19
API 2018 AGM - Results of Meeting23/01/19
API 2018 AGM - CEO Address to Shareholders23/01/19
API 2018 AGM - Chair's Address to Shareholders23/01/19
API 2018 AGM - Presentation to Shareholders23/01/19
API API - 2018 AGM arrangements16/01/19
API Becoming a substantial holder21/12/18
API Change of Director's Interest Notice19/12/18
API Change of Director's Interest Notice19/12/18
API SIG: Company Update14/12/18
API API merger proposal investor briefing14/12/18
API API merger proposal presentationPRICE SENSITIVE14/12/18
API API announces merger proposal with SigmaPRICE SENSITIVE14/12/18
API Becoming a substantial holder for SIG14/12/18
API Appendix 4G - Key to Disclosures07/12/18
API API 2018 Corporate Governance Statement07/12/18
API Proxy Form - 2018 Annual General Meeting07/12/18
API Notice of 2018 Annual General Meeting07/12/18
API 2018 Annual Report to Shareholders07/12/18
API Letter to Shareholders - 2018 Annual General Meeting07/12/18
API Letter to Shareholders - Final Dividend Payment07/12/18
API Change of Director's Interest Notice12/11/18
API Appendix 3B02/11/18
API FY18 - Results Presentation18/10/18
API FY18 Results - media release18/10/18
API Dividend/Distribution - API18/10/18
API Appendix 4E and FY18 Financial ReportPRICE SENSITIVE18/10/18
API API FY18 Financial Results12/10/18
API Becoming a substantial holder from CBA21/09/18
API Ceasing to be a substantial holder from CBA14/09/18
API Becoming a substantial holder from CBA12/09/18
API Ceasing to be a substantial holder from CBA06/09/18
API Becoming a substantial holder from CBA05/09/18
API Ceasing to be a substantial holder from CBA03/09/18
API Becoming a substantial holder from CBA31/08/18
API First stage of Clearskincare Clinics acquisition completePRICE SENSITIVE01/08/18
API Ceasing to be a substantial holder from CBA05/07/18
API Becoming a substantial holder from CBA02/07/18
API API Briefing 25 June 2018 - Clearskincare Clinics25/06/18
API API Presentation - Acquisition of Clearskincare ClinicsPRICE SENSITIVE25/06/18
API API to acquire Clearskincare ClinicsPRICE SENSITIVE25/06/18
API Letter to Shareholders - interim dividend payment01/06/18
API API HY18 Results Presentation19/04/18
API API HY18 Results ASX Release19/04/18
API Dividend/Distribution - API19/04/18
API API Half Yearly Report and AccountsPRICE SENSITIVE19/04/18
API API HY18 Financial Results13/04/18
API Change of Director's Interest Notice13/02/18
API Appendix 3B13/02/18
API Change of Director's Interest Notice07/02/18
API Change of Director's Interest Notice29/01/18
API Change of Director's Interest Notice29/01/18
API Appendix 3B29/01/18
API Change of Director's Interest Notice29/01/18
API Final Director's Interest Notice25/01/18
API 2017 AGM - Results of Meeting24/01/18
API 2017 AGM - CEO and MD Address to Shareholders24/01/18
API 2017 AGM - Chairman's Address to Shareholders24/01/18
API 2017 AGM - Presentation to Shareholders24/01/18
API API trading update and outlookPRICE SENSITIVE22/01/18
API API - 2017 AGM arrangements17/01/18
API Appendix 4G - Key to Disclosures08/12/17
API API 2017 Corporate Governance Statement08/12/17
API Proxy Form - 2017 Annual General Meeting08/12/17
API Notice of 2017 Annual General Meeting08/12/17
API 2017 Annual Report to Shareholders08/12/17
API Letter to Shareholders - 2017 Annual General Meeting08/12/17
API Letter to Shareholders - Final Dividend Payment08/12/17
API WHA: WHA Secures Distribution with APIPRICE SENSITIVE07/12/17
API Change of Director's Interest Notice23/11/17
API Appendix 3B17/11/17
API Change of Director's Interest Notice16/11/17
API Initial Director's Interest Notice09/11/17
API Director Appointment09/11/17
API Appendix 3B06/11/17
API Change of Director's Interest Notice03/11/17
API Appendix 3B03/11/17
API Appendix 3B03/11/17
API Change of Director's Interest Notice31/10/17
API Change of Director's Interest Notice26/10/17
API FY17 - Results Presentation19/10/17
API FY17 Results - media release19/10/17
API Dividend/Distribution - API19/10/17
API Appendix 4E and FY17 Financial ReportPRICE SENSITIVE19/10/17
API API FY17 Financial Results13/10/17
API Initial Director's Interest Notice06/09/17
API Appointment of Non-executive Director and Chair-elect06/09/17
API API - update on potential acquisitionPRICE SENSITIVE28/08/17
API API response to media speculationPRICE SENSITIVE07/08/17
API API - updated full year profit guidancePRICE SENSITIVE02/08/17
API S&P DJI Announces September 2019 Quarterly Rebalance
06/09/19PRICE SENSITIVE
API Change in substantial holding from CBA
22/03/19
API Market update on API-Sigma merger proposal
13/03/19PRICE SENSITIVE
API SIG: Update on API proposal
13/03/19PRICE SENSITIVE
API API presentation to ASX CEO Connect 19 February 2019
19/02/19
API Change of Director's Interest Notice
14/02/19
API Appendix 3B
14/02/19
API Change of Director's Interest Notice
31/01/19
API MDC: Medlab Expands Nutraceutical Range to 2,100 Pharmacies
30/01/19PRICE SENSITIVE
API API - Change in Company Office Holders
29/01/19
API Change of Director's Interest Notice
29/01/19
API 2018 AGM - Results of Meeting
23/01/19
API 2018 AGM - CEO Address to Shareholders
23/01/19
API 2018 AGM - Chair's Address to Shareholders
23/01/19
API 2018 AGM - Presentation to Shareholders
23/01/19
API API - 2018 AGM arrangements
16/01/19
API Becoming a substantial holder
21/12/18
API Change of Director's Interest Notice
19/12/18
API Change of Director's Interest Notice
19/12/18
API SIG: Company Update
14/12/18
API API merger proposal investor briefing
14/12/18
API API merger proposal presentation
14/12/18PRICE SENSITIVE
API API announces merger proposal with Sigma
14/12/18PRICE SENSITIVE
API Becoming a substantial holder for SIG
14/12/18
API Appendix 4G - Key to Disclosures
07/12/18
API API 2018 Corporate Governance Statement
07/12/18
API Proxy Form - 2018 Annual General Meeting
07/12/18
API Notice of 2018 Annual General Meeting
07/12/18
API 2018 Annual Report to Shareholders
07/12/18
API Letter to Shareholders - 2018 Annual General Meeting
07/12/18
API Letter to Shareholders - Final Dividend Payment
07/12/18
API Change of Director's Interest Notice
12/11/18
API Appendix 3B
02/11/18
API FY18 - Results Presentation
18/10/18
API FY18 Results - media release
18/10/18
API Dividend/Distribution - API
18/10/18
API Appendix 4E and FY18 Financial Report
18/10/18PRICE SENSITIVE
API API FY18 Financial Results
12/10/18
API Becoming a substantial holder from CBA
21/09/18
API Ceasing to be a substantial holder from CBA
14/09/18
API Becoming a substantial holder from CBA
12/09/18
API Ceasing to be a substantial holder from CBA
06/09/18
API Becoming a substantial holder from CBA
05/09/18
API Ceasing to be a substantial holder from CBA
03/09/18
API Becoming a substantial holder from CBA
31/08/18
API First stage of Clearskincare Clinics acquisition complete
01/08/18PRICE SENSITIVE
API Ceasing to be a substantial holder from CBA
05/07/18
API Becoming a substantial holder from CBA
02/07/18
API API Briefing 25 June 2018 - Clearskincare Clinics
25/06/18
API API Presentation - Acquisition of Clearskincare Clinics
25/06/18PRICE SENSITIVE
API API to acquire Clearskincare Clinics
25/06/18PRICE SENSITIVE
API Letter to Shareholders - interim dividend payment
01/06/18
API API HY18 Results Presentation
19/04/18
API API HY18 Results ASX Release
19/04/18
API Dividend/Distribution - API
19/04/18
API API Half Yearly Report and Accounts
19/04/18PRICE SENSITIVE
API API HY18 Financial Results
13/04/18
API Change of Director's Interest Notice
13/02/18
API Appendix 3B
13/02/18
API Change of Director's Interest Notice
07/02/18
API Change of Director's Interest Notice
29/01/18
API Change of Director's Interest Notice
29/01/18
API Appendix 3B
29/01/18
API Change of Director's Interest Notice
29/01/18
API Final Director's Interest Notice
25/01/18
API 2017 AGM - Results of Meeting
24/01/18
API 2017 AGM - CEO and MD Address to Shareholders
24/01/18
API 2017 AGM - Chairman's Address to Shareholders
24/01/18
API 2017 AGM - Presentation to Shareholders
24/01/18
API API trading update and outlook
22/01/18PRICE SENSITIVE
API API - 2017 AGM arrangements
17/01/18
API Appendix 4G - Key to Disclosures
08/12/17
API API 2017 Corporate Governance Statement
08/12/17
API Proxy Form - 2017 Annual General Meeting
08/12/17
API Notice of 2017 Annual General Meeting
08/12/17
API 2017 Annual Report to Shareholders
08/12/17
API Letter to Shareholders - 2017 Annual General Meeting
08/12/17
API Letter to Shareholders - Final Dividend Payment
08/12/17
API WHA: WHA Secures Distribution with API
07/12/17PRICE SENSITIVE
API Change of Director's Interest Notice
23/11/17
API Appendix 3B
17/11/17
API Change of Director's Interest Notice
16/11/17
API Initial Director's Interest Notice
09/11/17
API Director Appointment
09/11/17
API Appendix 3B
06/11/17
API Change of Director's Interest Notice
03/11/17
API Appendix 3B
03/11/17
API Appendix 3B
03/11/17
API Change of Director's Interest Notice
31/10/17
API Change of Director's Interest Notice
26/10/17
API FY17 - Results Presentation
19/10/17
API FY17 Results - media release
19/10/17
API Dividend/Distribution - API
19/10/17
API Appendix 4E and FY17 Financial Report
19/10/17PRICE SENSITIVE
API API FY17 Financial Results
13/10/17
API Initial Director's Interest Notice
06/09/17
API Appointment of Non-executive Director and Chair-elect
06/09/17
API API - update on potential acquisition
28/08/17PRICE SENSITIVE
API API response to media speculation
07/08/17PRICE SENSITIVE
API API - updated full year profit guidance
02/08/17PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Cyclone signs MOU with Vale for development of Iron Bear play

Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.